Violation Tracker Individual Record

Company: 
Janssen Pharmaceuticals, Inc.
Current Parent Company: 
Johnson & Johnson
Penalty: 
$181,000,000
Year: 
2012
Date: 
August 30, 2012
Offense Group: 
healthcare-related offenses
Primary Offense: 
off-label or unapproved promotion of medical products
Violation Description: 

Janssen Pharmaceuticals, Inc. and its parent company Johnson & Johnson agreed to pay $181 million to resolve multistate litigation alleging improper marketing and advertising of the powerful anti-psychotic drugs Risperdal and Invega.

Level of Government: 
state
Action Type: 
agency action
Agency: 
Multistate Attorneys General Case
Civil or Criminal Case: 
civil
HQ Country of Parent: 
USA
HQ State of Parent: 
New Jersey
Ownership Structure of Parent: 
publicly traded
Major Industry of Parent: 
pharmaceuticals
Specific Industry of Parent: 
pharmaceuticals
Source Notes: 
If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Parent company note: 
Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.